102 related articles for article (PubMed ID: 33255418)
1. A Potential Serum
Higashi M; Yoshimura T; Usui N; Kano Y; Deguchi A; Tanabe K; Uchimura Y; Kuriyama S; Suzuki Y; Masaki T; Ikenaka K
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255418
[TBL] [Abstract][Full Text] [Related]
2. Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma.
Weis A; Marquart L; Calvopina DA; Genz B; Ramm GA; Skoien R
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781550
[TBL] [Abstract][Full Text] [Related]
3. Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma.
Manuc D; Preda CM; Sandra I; Baicus C; Cerban R; Constantinescu I; Olteanu AO; Ciora CA; Manuc T; Chiriac DE; Chifulescu AE; Diculescu M; Tieranu C; Negreanu L; Oprea-Calin G; Manuc M
J Med Life; 2020; 13(1):68-74. PubMed ID: 32341704
[TBL] [Abstract][Full Text] [Related]
4. Clinical Utility of Cytokeratins for Accurate Diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response.
Chida T; Ohta K; Noritake H; Matsushita M; Murohisa G; Kageyama F; Sasada Y; Oyaizu T; Tsugiki M; Tamakoshi K; Nakajima T; Suda T; Kawata K
Sci Rep; 2024 May; 14(1):10864. PubMed ID: 38740815
[TBL] [Abstract][Full Text] [Related]
6. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma.
Li B; Li B; Guo T; Sun Z; Li X; Li X; Wang H; Chen W; Chen P; Mao Y
Biomed Res Int; 2017; 2017():5358615. PubMed ID: 28540298
[TBL] [Abstract][Full Text] [Related]
8. Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus.
Abdelwahab FA; Hassanein KM; Hetta HF; Abdelmalek MO; Zahran AM; El-Badawy O
Sci Rep; 2020 Nov; 10(1):20383. PubMed ID: 33230233
[TBL] [Abstract][Full Text] [Related]
9. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Dengler M; Staufer K; Huber H; Stauber R; Bantel H; Weiss KH; Starlinger P; Pock H; Klöters-Plachky P; Gotthardt DN; Rauch P; Lackner C; Stift J; Brostjan C; Gruenberger T; Kumada T; Toyoda H; Tada T; Weiss TS; Trauner M; Mikulits W
Oncotarget; 2017 Jul; 8(28):46234-46248. PubMed ID: 28526812
[TBL] [Abstract][Full Text] [Related]
10. Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?
Singal AG; Nehra M; Adams-Huet B; Yopp AC; Tiro JA; Marrero JA; Lok AS; Lee WM
Am J Gastroenterol; 2013 Mar; 108(3):425-32. PubMed ID: 23337478
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.
Gehrau RC; Archer KJ; Mas VR; Maluf DG
PLoS One; 2012; 7(7):e40275. PubMed ID: 22792259
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis.
Abara WE; Spradling P; Zhong Y; Moorman A; Teshale EH; Rupp L; Gordon SC; Schmidt M; Boscarino JA; Daida YG; Holmberg SD;
J Gastrointest Cancer; 2020 Jun; 51(2):461-468. PubMed ID: 31124041
[TBL] [Abstract][Full Text] [Related]
13. Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma.
Yin H; Lin Z; Nie S; Wu J; Tan Z; Zhu J; Dai J; Feng Z; Marrero J; Lubman DM
J Proteome Res; 2014 Jun; 13(6):2887-96. PubMed ID: 24799124
[TBL] [Abstract][Full Text] [Related]
14. Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis.
Ressom HW; Xiao JF; Tuli L; Varghese RS; Zhou B; Tsai TH; Ranjbar MR; Zhao Y; Wang J; Di Poto C; Cheema AK; Tadesse MG; Goldman R; Shetty K
Anal Chim Acta; 2012 Sep; 743():90-100. PubMed ID: 22882828
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in pregnancy: A systematic review.
Marasciulo F; Passerini I; Fichera A; Ferrari F; Odicino FE; Prefumo F
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):653-659. PubMed ID: 37533304
[TBL] [Abstract][Full Text] [Related]
16. Doylestown Plus and GALAD Demonstrate High Sensitivity for HCC Detection in Patients With Cirrhosis.
Singal AG; Tayob N; Mehta A; Marrero JA; Jin Q; Lau J; Parikh ND
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):953-955.e2. PubMed ID: 33864933
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue.
Mehta A; Norton P; Liang H; Comunale MA; Wang M; Rodemich-Betesh L; Koszycki A; Noda K; Miyoshi E; Block T
Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):925-33. PubMed ID: 22490318
[TBL] [Abstract][Full Text] [Related]
18. Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC).
Lu F; Ott C; Bista P; Lu X
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611638
[TBL] [Abstract][Full Text] [Related]
19. A Rare Case of Isolated Hepatocellular Carcinoma Metastasis in Left Mandibular Region in a Patient with Hepatitis C Virus Liver Cirrhosis Diagnosed after the Onset of COVID-19 Infection.
Mašulović D; Igić A; Filipović A; Zakošek M; Bulatović D; Mijović K; Micev M; Galun D
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004041
[No Abstract] [Full Text] [Related]
20. Rising plasma nociceptin level during development of HCC: a case report.
Horvath A; Folhoffer A; Lakatos PL; Halosz J; Illyes G; Schaff Z; Hantos MB; Tekes K; Szalay F
World J Gastroenterol; 2004 Jan; 10(1):152-4. PubMed ID: 14695788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
